Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple‐negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta-Reference-Cited by-同舟云学术

Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple‐negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta

Published:2022-01 Issue:1 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Jian Yunting¹²,Kong Lingzhi¹,Xu Hongyi¹³,Shi Yawei⁴,Huang Xinjian¹,Zhong Wenjing¹³,Huang Shumei⁵,Li Yue¹,Shi Dongni¹,Xiao Yunyun¹,Yang Muwen¹,Li Siqi¹³,Chen Xiangfu¹,Ouyang Ying¹,Hu Yameng⁵,Chen Xin⁶,Song Libing¹,Ye Runyi⁴,Wei Weidong¹³^ORCID

Affiliation:

1. Department of Experimental Research, Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangzhou China

2. Department of Pathology, Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, Key Laboratory for Major Obstetric Diseases of Guangdong Province The Third Affiliated Hospital of Guangzhou Medical University Guangzhou China

3. Department of Breast Surgery Sun Yat‐sen University Cancer Center Guangzhou China

4. Department of Thyroid and Breast Surgery The First Affiliated Hospital of Sun Yat‐sen University Guangzhou China

5. Department of Biochemistry, Zhongshan School of Medicine Sun Yat‐sen University Guangzhou China

6. Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences; Guangzhou Institute of Oncology Tumor Hospital, Guangzhou Medical University Guangzhou China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.725

Reference55 articles.

1. Triple-Negative Breast Cancer